TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time course changes of biochemical, physiologic, and nutritional objectives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain-NRS changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin resistance as expressed by HOMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting glucagon levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting amylin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: E-point septal separation and fractional shortening correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Level of serum inflammatory cytokines (ESR, TNF-alpha, ICAM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stress hormone levels (ADH, ACTH, cortisol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increase in PCr/ATP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Recovery rates from exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Symptom relief (epigastric pain and vomiting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patients' global evaluation of treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: times to glottis exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: times to tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CLV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bioavailability of intravesical oxybutynin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systemic exposure to racemic oxybutynin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerance of study medication
Endpoint domain: Adverse events/effects
Primary endpoint: Carotid IMT decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Deaths related to abdominal aortic aneurysms
Endpoint domain: Mortality/survival
Primary endpoint: Incremental cost effectiveness ratio per life year gained
Endpoint domain: Resource use
Primary endpoint: Quality adjusted life year
Endpoint domain: Resource use
Primary endpoint: Reduction of psoriasis area and severity index (PASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Clearing of sides treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Onset of improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: NT-Pro-BNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CPC prediction by preoperative NT-Pro-BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed abstainers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postintervention test rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL:HDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical response to melaleuca oral solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chest drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative transfusion requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of reoperations for hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ≥50% reductions in average postamputation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to first drink
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SNP-induced inhibition of platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of symptomatic ischaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anginal frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume in the first second (FEV1%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced vital capacity (FVC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fat volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in vitamin D status over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postextubation atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak inflation pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Major pulmonary and anastomotic complications
Endpoint domain: Mortality/survival
Primary endpoint: Quality of Life (QoL) response
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of peristomal and other infections
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically important wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Non-wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Total laboratory energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleeding VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new male HIV infections
Endpoint domain: Mortality/survival
Primary endpoint: Mean changes in Kupperman index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and intensity of vaginal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in insulin-like growth factor I and sex hormone binding globulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Progression of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-of-Life improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in analgesic intake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: unplanned transfers to a higher level of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: shoulder abduction strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IHOT-33 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 15-minute sitting pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cervical cancer screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of cancer on sexual function
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma levels of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Family functioning outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postbooster BMEM frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Identification of operated tooth by laypeople
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of operated tooth by orthodontists
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for unoperated canine appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of anticipatory nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensorineural hearing loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: XeQoLS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attenuation of SDys
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of complications after index surgery
Endpoint domain: Adverse events/effects
Primary endpoint: time to first unplanned hospital readmission or ER visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: early unplanned health care utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: footprint heel bisector measurement improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS FA score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Improvement of general health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in binge days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zones of differential sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mental health service use attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Insulin therapy self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 10-year renal survival
Endpoint domain: Mortality/survival
Primary endpoint: Cosmetic appearance of scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of contact dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of functional balance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe neonatal morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in TCM syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of dry mouth
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Greater oral intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Less need for intravenous rehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Type-II error rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of positive postoperative cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microflora changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak FBF response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total reactive hyperaemic flow (FDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Functional disability levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: insulin sensitivity (M/I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prosody identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reward processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Major improvement in self-reported bladder-related problems
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Treatment response rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feeling physically better
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Discharge rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Plasma hGH concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood loss in the first 4 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: incidence of adverse effects (shivering/pyrexia)
Endpoint domain: Adverse events/effects
Primary endpoint: Median Time to Response (TTR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammatory acne lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of inversion ankle sprains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: venous patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: incidence of post-thrombotic syndrome (PTS)
Endpoint domain: Adverse events/effects
Primary endpoint: Intraoperative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee joint function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional connectivity between pACC and amygdala
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inconvenience of administration, leaking out and interference with coitus
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stunting at 12 months postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total plasma antioxidant potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of MUC1 and Met-HGF/SF in axillary fluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lung volume estimation accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Preference for Quicktrach™ kit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with the quality of the service
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient costs for telemedicine
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DV(90%Adv)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete lumen preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vessel volume change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PASI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported functional performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: DD (dyspnea during activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total serum protein, albumin and IgG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impaired humoral and cellular immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Iron store depletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum TGF-beta levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: blood pressure rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adherence to reporting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: improvement in functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trough FEV1 at Day 84
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: proportion of FEV1 responders at Day 84
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of clinically driven target lesion revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: rates of major bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: weight loss maintenance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of unprotected sex episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about AIDS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: snack food liking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of the PCR technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of CVD or cancer
Endpoint domain: Mortality/survival
Primary endpoint: Mean percentage change in FBF before cold stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Mean percentage change in FBF after cold stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Improvement in RP VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV diagnosis testing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stray light values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photopic and mesopic contrast acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glare symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accessibility
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: behavioral intention
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Total LDL particle size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intramuscular temperature increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful discontinuation of benzodiazepine treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T3/rT3 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Restoration of microbial diversity and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Early Recurrence of Atrial Fibrillation (ERAF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Late Recurrence of Atrial Fibrillation (LR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early improvement (≥20% MADRS Total score reduction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesion count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: A' (septal) velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sm (septal) velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: BS nutrition knowledge score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries increment after 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety (STAI, HADS‐A)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fatigue (MFI)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: depression (HADS‐D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life (QOL) change from baseline to week 2
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life (QOL) scores at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: oral mucous membrane integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between patient self-report and CRFs/medical records
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma TGF-beta1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of carotid atherosclerosis (IMT change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Seroprotective serum bactericidal assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: >4-fold rise in serum bactericidal assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Average daily step count increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention